FI823274A0 - Laekemedel, daeri innehaollna vicinala dihydroxialkylxantiner, framstaellningsfoerfaranden foer dessxantinfoereningar och foer dessa laempade mellanprodukter - Google Patents

Laekemedel, daeri innehaollna vicinala dihydroxialkylxantiner, framstaellningsfoerfaranden foer dessxantinfoereningar och foer dessa laempade mellanprodukter

Info

Publication number
FI823274A0
FI823274A0 FI823274A FI823274A FI823274A0 FI 823274 A0 FI823274 A0 FI 823274A0 FI 823274 A FI823274 A FI 823274A FI 823274 A FI823274 A FI 823274A FI 823274 A0 FI823274 A0 FI 823274A0
Authority
FI
Finland
Prior art keywords
omega
atoms
compounds
chain
radicals
Prior art date
Application number
FI823274A
Other languages
English (en)
Other versions
FI73681B (fi
FI73681C (fi
FI823274L (fi
Inventor
Harald Furrer
Hiristo Anagnostopulos
Ulrich Gebert
Heinz-Joachim Hinze
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI823274A0 publication Critical patent/FI823274A0/fi
Publication of FI823274L publication Critical patent/FI823274L/fi
Publication of FI73681B publication Critical patent/FI73681B/fi
Application granted granted Critical
Publication of FI73681C publication Critical patent/FI73681C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/09Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis
    • C07C29/10Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of ethers, including cyclic ethers, e.g. oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/34Halogenated alcohols
    • C07C31/42Polyhydroxylic acyclic alcohols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/08Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/16Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/20Free hydroxyl or mercaptan
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pyrane Compounds (AREA)
FI823274A 1981-09-26 1982-09-23 Foerfarande foer framstaellning av terapeutiskt anvaendbara dihydroxialkylsubstituerade xantinderivat. FI73681C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19813138397 DE3138397A1 (de) 1981-09-26 1981-09-26 "arzneimittel, darin enthaltene vicinale dihydroxyalkylxanthine und herstellungsverfahren fuer diese xanthinverbindungen"
DE3138397 1981-09-26

Publications (4)

Publication Number Publication Date
FI823274A0 true FI823274A0 (fi) 1982-09-23
FI823274L FI823274L (fi) 1983-03-27
FI73681B FI73681B (fi) 1987-07-31
FI73681C FI73681C (fi) 1987-11-09

Family

ID=6142714

Family Applications (1)

Application Number Title Priority Date Filing Date
FI823274A FI73681C (fi) 1981-09-26 1982-09-23 Foerfarande foer framstaellning av terapeutiskt anvaendbara dihydroxialkylsubstituerade xantinderivat.

Country Status (18)

Country Link
US (2) US4616020A (fi)
EP (1) EP0075850B1 (fi)
JP (1) JP2550301B2 (fi)
KR (1) KR880002300B1 (fi)
AT (1) ATE17005T1 (fi)
AU (1) AU554227B2 (fi)
CA (1) CA1286292C (fi)
DE (2) DE3138397A1 (fi)
DK (1) DK148844C (fi)
ES (3) ES8606346A1 (fi)
FI (1) FI73681C (fi)
GR (1) GR76734B (fi)
HU (1) HU186125B (fi)
IE (1) IE53911B1 (fi)
IL (1) IL66864A0 (fi)
NO (1) NO158678C (fi)
PT (1) PT75604B (fi)
ZA (1) ZA827012B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
AU607929B2 (en) * 1986-08-07 1991-03-21 Medice Chem.-Pharm. Fabrik Putter Gmbh & Co. Kg Pharmaceutical preparations
FR2611716A1 (fr) * 1987-03-06 1988-09-09 Uriach Cia Sa J Derives de diisobutylxanthine substituee en position 7 utiles comme bronchodilatateurs, procede pour leur preparation et composition pharmaceutique les contenant
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤
DE4109169A1 (de) * 1991-03-20 1992-09-24 Koehler Chemie Dr Franz Wasserloesliche nicht ionische roentgenkontrastmittel sowie mittel und verfahren zu ihrer herstellung
US5342841A (en) * 1992-03-12 1994-08-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
US6469017B1 (en) * 1998-01-16 2002-10-22 Cell Therapeutics, Inc. Method of inhibiting interleukin-12 signaling
US5473070A (en) * 1992-11-16 1995-12-05 Cell Therapeutics, Inc. Substituted long chain alcohol xanthine compounds
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5446046A (en) * 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
CA2206287C (en) * 1994-12-13 2001-03-20 Mark Chasin Aryl thioxanthines
EP0799040B1 (en) * 1994-12-13 2003-08-20 Euroceltique S.A. Trisubstituted thioxanthines
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
US6576619B2 (en) 1999-05-24 2003-06-10 Cv Therapeutics, Inc. Orally active A1 adenosine receptor agonists
MXPA03001741A (es) * 2000-09-08 2004-09-10 Cv Therapeutics Inc Ribosidos de purina como antiarritmicos.
JP4483683B2 (ja) 2005-04-28 2010-06-16 日立工機株式会社 連ねじドライバ

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2575344A (en) * 1946-03-01 1951-11-20 State Of Iowa Dihydroxypropyl theophylline
US2517410A (en) * 1947-08-15 1950-08-01 Searle & Co Hydroxy alkyl xanthines and the production thereof
DE2335170C2 (de) * 1973-07-11 1989-07-20 Hoechst Ag, 6230 Frankfurt 1,3-Dialkyl-7-(hydroxyalkyl)-xanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen
US4031218A (en) * 1976-04-28 1977-06-21 Mallinckrodt, Inc. 7-(2,3-Dihydroxypropyl-1,3-di-n-propylxanthine and a pharmaceutical composition containing same useful as a bronchial muscle relaxant
US4397779A (en) * 1978-08-09 1983-08-09 Baxter Travenol Laboratories, Inc. Preparation of xanthine tracers
IL59664A0 (en) * 1979-04-05 1980-06-30 Wuelfing J Kg Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions
IT1195267B (it) * 1980-04-15 1988-10-12 Abc Ist Biolog Chem Spa Derivati teofillinmetildiossolanici,procedimento per la loro preparazione e relative composizioni farmaceutiche

Also Published As

Publication number Publication date
DK148844B (da) 1985-10-21
IE53911B1 (en) 1989-04-12
ES8606346A1 (es) 1986-04-01
EP0075850A2 (de) 1983-04-06
NO158678B (no) 1988-07-11
PT75604B (de) 1985-07-26
EP0075850B1 (de) 1985-12-18
AU554227B2 (en) 1986-08-14
FI73681B (fi) 1987-07-31
DE3138397A1 (de) 1983-04-07
PT75604A (de) 1982-10-01
JP2550301B2 (ja) 1996-11-06
CA1286292C (en) 1991-07-16
FI73681C (fi) 1987-11-09
DK148844C (da) 1986-03-17
DE3268041D1 (en) 1986-01-30
EP0075850A3 (en) 1983-07-27
GR76734B (fi) 1984-08-30
ES528122A0 (es) 1984-08-01
IL66864A0 (en) 1982-12-31
US4616020A (en) 1986-10-07
HU186125B (en) 1985-06-28
ZA827012B (en) 1983-07-27
ES528123A0 (es) 1984-08-16
FI823274L (fi) 1983-03-27
ES8406479A1 (es) 1984-08-01
ES515936A0 (es) 1986-04-01
NO158678C (no) 1988-10-19
AU8866382A (en) 1983-04-14
DK426982A (da) 1983-03-27
JPS5867687A (ja) 1983-04-22
ATE17005T1 (de) 1986-01-15
US4713455A (en) 1987-12-15
ES8407048A1 (es) 1984-08-16
IE822322L (en) 1983-03-26
KR880002300B1 (ko) 1988-10-22
KR840001576A (ko) 1984-05-07
NO823239L (no) 1983-03-28

Similar Documents

Publication Publication Date Title
FI823274A0 (fi) Laekemedel, daeri innehaollna vicinala dihydroxialkylxantiner, framstaellningsfoerfaranden foer dessxantinfoereningar och foer dessa laempade mellanprodukter
DK518683D0 (da) Fremgangsmade til fremstilling af 4"epi-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a eller farmaceutisk acceptable syreadditionssalte deraf og mellemprodukter ved fremgangsmaden
SE7514518L (sv) Azolyl-(1)-metaner och salter derav till anvendning som lekemedel och sett for deras framstellning
FI801599A (fi) Foerfarande foer tillverkning av diaryletrar
DE3381964D1 (de) Dithio-verbindungen, diese enthaltende pharmazeutische praeparate und deren verwendung.
SE8601852D0 (sv) Cyklopentyletrar och deras framstellning och farmaceutiska beredning
CH614433A5 (en) Use of diaryloxytriazolyl-O,N-acetals and their salts for controlling fungi
FI830397L (fi) Foerfarande foer framstaellning av imidazolidinderivat
IT1159151B (it) Steroidi esterificati nella posizione 17 e tioesterificati nella posizione 21 loro procedimento di preparazione e loro uso medicinale
ES511365A0 (es) "procedimiento de preparacion de derivados de fenetanolamina".
ES515640A0 (es) "un procedimiento para la preparacion de pirimid-2-onas".
MX155296A (es) Procedimiento para preparar derivados de tiazol
SE7708452L (sv) Komposition innehallande en antrakinonforening
SE8004351L (sv) (3-alkylamino-2-hydroxipropoxi)-furan-2-karbonsyra-anilider och fysiologiskt fordragbara syraadditionssalter derav samt lekemedel med en halt av dessa foreningar
FR2448544A1 (fr) Derives de thiazole et leur application en therapeutique
SE8204791L (sv) Sett att framstella alkoxivinkaminsyraestrar och alkoxiapovinkaminsyraestrar
ES549998A0 (es) Procedimiento para la preparacion de 13 a-alquilgonanos
ES469955A1 (es) Un procedimiento para la preparacion de derivados de 2-naf- tilamina

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT